Publication:
High-mobility group box (TOX) antibody a useful tool for the identification of B and T cell subpopulations.

dc.contributor.authorGarcía-García, Juan Fernando
dc.contributor.authorJiménez, Scherezade
dc.contributor.authorReyes-García, Ana Isabel
dc.contributor.authorGarcía-González, Álvaro
dc.contributor.authorMontes-Moreno, Santiago
dc.contributor.authorArribas, Alberto J
dc.contributor.authorBanham, Alison H
dc.contributor.authorPiris, Miguel Ángel
dc.contributor.authorRoncador, Giovanna
dc.contributor.authorMaestre, Maestre L
dc.contributor.authorGonzalez Garcia, Patricia
dc.contributor.authorCaleiras, E
dc.contributor.funderEuropean Commission
dc.contributor.funderComunidad de Madrid
dc.contributor.funderInstituto de Salud Carlos III
dc.date.accessioned2021-05-20T09:42:11Z
dc.date.available2021-05-20T09:42:11Z
dc.date.issued2020-02-27
dc.description.abstractThymocyte selection-associated high-mobility group box (TOX) is a DNA-binding factor that is able to regulate transcription by modifying local chromatin structure and modulating the formation of multi-protein complexes. TOX has multiple roles in the development of the adaptive immune system including development of CD4 T cells, NK cells and lymph node organogenesis. However very few antibodies recognizing this molecule have been reported and no extensive study of the expression of TOX in reactive and neoplastic lymphoid tissue has been performed to date. In the present study, we have investigated TOX expression in normal and neoplastic lymphoid tissues using a novel rat monoclonal antibody that recognizes its target molecule in paraffin-embedded tissue sections. A large series of normal tissues and B- and T-cell lymphomas was studied, using whole sections and tissue microarrays. We found that the majority of precursor B/T lymphoblastic, follicular and diffuse large B-cell lymphomas, nodular lymphocyte-predominant Hodgkin lymphomas and angioimmunoblastic T-cell lymphomas strongly expressed the TOX protein. Burkitt and mantle cell lymphomas showed TOX expression in a small percentage of cases. TOX was not found in the majority of chronic lymphocytic leukemia, myelomas, marginal zone lymphomas and classical Hodgkin lymphomas. In conclusion, we describe for the first time the expression of TOX in normal and neoplastic lymphoid tissues. The co-expression of TOX and PD-1 identified in normal and neoplastic T cells is consistent with recent studies identifying TOX as a critical regulator of T-cell exhaustion and a potential immunotherapy target. Its differential expression may be of diagnostic relevance in the differential diagnosis of follicular lymphoma, the identification of the phenotype of diffuse large B-cell lymphoma and the recognition of peripheral T-cell lymphoma with a follicular helper T phenotype.es_ES
dc.description.peerreviewedes_ES
dc.description.sponsorshipThis work was supported by grants from the Plan Nacional de I+D+I, co-financed by the ISCIII-Subdireccion General de Evaluacion and the Fondo Europeo de Desarrollo Regional (FEDER), CIBERONC -CB16/12/00291 (MAP), and Programs of R&D activities among research groups of the Community of Madrid in Biomedicine (B2017/BMD-3778) (MAP, GR, JFGG). All funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.es_ES
dc.format.number2es_ES
dc.format.pagee0229743es_ES
dc.format.volume15es_ES
dc.identifier.citationPLoS One.2020;15(2):e0229743es_ES
dc.identifier.doi10.1371/journal.pone.0229743es_ES
dc.identifier.e-issn1932-6203es_ES
dc.identifier.journalPloS onees_ES
dc.identifier.pubmedID32106280es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/12981
dc.language.isoenges_ES
dc.publisherBioMed Central (BMC)
dc.relation.publisherversionhttps://doi.org/10.1371/journal.pone.0229743.es_ES
dc.repisalud.institucionCNIOes_ES
dc.repisalud.orgCNIOCNIO::Unidades técnicas::Unidad de Anticuerpos Monoclonaleses_ES
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAtribución-NoComercial-CompartirIgual 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/*
dc.subject.meshAnimalses_ES
dc.subject.meshAntibodies, Monoclonal, Murine-Derivedes_ES
dc.subject.meshAntibody Specificityes_ES
dc.subject.meshB-Lymphocyte Subsetses_ES
dc.subject.meshCell Line, Tumores_ES
dc.subject.meshFemalees_ES
dc.subject.meshGene Expressiones_ES
dc.subject.meshHigh Mobility Group Proteinses_ES
dc.subject.meshHumanses_ES
dc.subject.meshLymphoid Tissuees_ES
dc.subject.meshLymphoma, B-Celles_ES
dc.subject.meshLymphoma, T-Celles_ES
dc.subject.meshMalees_ES
dc.subject.meshMicees_ES
dc.subject.meshMice, Inbred C57BLes_ES
dc.subject.meshRNA, Messengeres_ES
dc.subject.meshRatses_ES
dc.subject.meshRats, Wistares_ES
dc.subject.meshT-Lymphocyte Subsetses_ES
dc.titleHigh-mobility group box (TOX) antibody a useful tool for the identification of B and T cell subpopulations.es_ES
dc.typejournal articlees_ES
dc.type.hasVersionVoRes_ES
dspace.entity.typePublication
relation.isAuthorOfPublicationed512382-68d2-4ded-b890-b84f9140f38c
relation.isAuthorOfPublication20efbd2b-6ace-4920-a361-043192072dfe
relation.isAuthorOfPublicationd684aa7c-7a4d-4267-a959-41e1eee1bd45
relation.isAuthorOfPublication1f2cd155-f0eb-44cb-9a03-5ff0246a94dd
relation.isAuthorOfPublication.latestForDiscoveryed512382-68d2-4ded-b890-b84f9140f38c
relation.isFunderOfPublication7d739953-4b68-4675-b5bb-387a9ab74b66
relation.isFunderOfPublication.latestForDiscovery7d739953-4b68-4675-b5bb-387a9ab74b66
relation.isPublisherOfPublication4fe896aa-347b-437b-a45b-95f4b60d9fd3
relation.isPublisherOfPublication.latestForDiscovery4fe896aa-347b-437b-a45b-95f4b60d9fd3

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
high-mobilitygroup_2020.pdf
Size:
3.46 MB
Format:
Adobe Portable Document Format
Description:
Artículo principal